Previous conclusive evidence has shown that the tumour-related inflammatory system is essential for tumour angiogenesis and tumorigenesis and that two parameters (fibrinogen and CRP/Alb) of inflammation-based biomarkers may be associated with the prognosis of pancreatic carcinoma (23–25). This evidence concerns the gene CRP and exocrine pancreatic carcinoma.